Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Holding MDT?
Track your performance easily
MDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$75.96 - $92.68
Previous Close$82.48
Volume6.35M
Average Volume (3M)6.09M
Market Cap
$105.76B
Enterprise Value$126.32B
Total Cash (Recent Filing)$7.99B
Total Debt (Recent Filing)$28.33B
Price to Earnings (P/E)25.2
Beta0.64
Next Earnings
Feb 18, 2025EPS Estimate
$1.36Next Dividend Ex-Date
Dec 27, 2024Dividend Yield3.37%
Share Statistics
EPS (TTM)3.28
Shares Outstanding1,282,285,681
10 Day Avg. Volume5,467,292
30 Day Avg. Volume6,088,817
Standard Deviation0.07
R-Squared0.43
Alpha-0.00989
Financial Highlights & Ratios
Price to Book (P/B)2.18
Price to Sales (P/S)3.21
Price to Cash Flow (P/CF)27.60
P/FCF Ratio40.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.83
Enterprise Value/Gross Profit5.97
Enterprise Value/Ebitda14.76
Forecast
1Y Price Target
$96.23Price Target Upside18.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Medtronic News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMedtronic delivered better-than-expected FY2Q25 results, with revenue exceeding consensus, marking the eighth quarter of MSD revenue growth.
Growth GuidanceAnalysts see more upside than downside for Medtronic over the next twelve months, driven by consistent revenue growth and potential contribution from new product launches.
Product LaunchesMedtronic's ongoing and upcoming cadence of new product launches should sustain a mid-single-digit revenue growth trajectory.
Bears Say
Financial PerformanceAdjusted operating margin was slightly below expectations, reflecting ongoing supply chain pressures and cost-saving program delays.
Interest And DevelopmentHigh interest rates may limit Medtronic's research and development capabilities, potentially delaying new product launches that could drive share price growth.
Market CompetitionThe growing popularity of GLP-1 drugs could significantly impact Medtronic's insulin pump sales, with a risk of losing 50% of its market share.
---
Ownership Overview
0.07% Insiders
24.86% Mutual Funds
18.79% Other Institutional Investors
35.91% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $75.96 and its highest was $92.68 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is Feb 18, 2025 which is in 62 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Nov 19, 2024. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.25 by $0.01.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.699 which represents an annual dividend yield of 3.37%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.36.
How many shares outstanding does Medtronic have?
Medtronic has 1,282,285,600 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.26 in its last earnings report, beating expectations of $1.25. Following the earnings report the stock price went down -2.957%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 879M.
---
Medtronic Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$96.23 (18.29% Upside)
$96.23 (18.29% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 94%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 889.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.11%
12-Months-Change
Fundamentals
Return on Equity
8.58%
Trailing 12-Months
Asset Growth
-0.05%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
MDT Company Deck
---
MDT Earnings Call
Q2 2024
0:00 / 0:00
---
MDT Net sales Breakdown
36.56% Cardiovascular
29.06% Neuroscience
26.01% Medical Surgical
7.69% Diabetes
0.68% Other operating segment
---
MDT Stock 12 Month Forecast
Average Price Target
$96.23
▲(18.29% Upside)
Technical Analysis
Best Analysts Covering MDT
1 Year
1 Year Success Rate
20/30 ratings generated profit
1 Year Average Return
+7.77%
reiterated a buy rating 23 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +7.77% per trade.
---